Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$757K Sell
5,889
-64
-1% -$7.49K 0.46% 53
2026
Q1
$716K Sell
5,953
-88
-1% -$10.2K 0.51% 55
2025
Q4
$636K Sell
6,041
-42
-0.7% -$3.94K 0.46% 54
2025
Q3
$511K Buy
+6,083
New +$501K 0.38% 66
2025
Q1
$571K Buy
6,361
+11
+0.2% +$1.03K 0.49% 58
2024
Q4
$635K Sell
6,350
-952
-13% -$98.1K 0.55% 57
2024
Q3
$742K Buy
+7,302
New +$868K 0.62% 54

Other funds holding MRK

Shum Financial Group's MRK Position: Q2 2026 in Review

Shum Financial Group reduced its Merck (MRK) stake by 1.1% in Q2 2026, selling an estimated $7.49K and leaving 5,889 shares worth $757K. The position accounts for 0.46% of the portfolio, ranked #53.

Shum Financial Group first reported a position in MRK in Q3 2024 and has held it in 7 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Shum Financial Group held 5,889 shares of Merck worth $757K as of Q2 2026.
  • Shum Financial Group sold 64 Merck shares in Q2 2026, an estimated $7.49K.
  • Merck made up 0.46% of Shum Financial Group's portfolio in Q2 2026, its #53 holding.
  • Shum Financial Group first reported a position in Merck in Q3 2024 and has held it in 7 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Shum Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.